Hormonal Actions and Interactions in Proximal Tubule Cells Associated with the Development of Chronic Kidney Disease by Akihiko Saito et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
  
13 
Hormonal Actions and Interactions in  
Proximal Tubule Cells Associated with  
the Development of Chronic Kidney Disease 
Akihiko Saito1, Michihiro Hosojima2 and Hiroyoshi Sato1 
1Department of Applied Molecular Medicine 
 2Division of Clinical Nephrology and Rheumatology 
Niigata University Graduate School of Medical and Dental Sciences 
Japan 
1. Introduction 
As the first tubular segment of the kidney between the Bowman’s capsule and the loop of 
Henle, the proximal tubule is exposed to initial glomerular filtrates. Proximal tubule cells 
(PTCs) have a variety of functions including 1) reabsorption and intracellular processing of 
glomerular-filtered substances such as proteins, peptides, glucose, amino acids, uric acid, 
sodium, potassium, phosphate, bicarbonate and water via apical membrane receptors, 
transporters, and channels; 2) uptake of substances such as protein-bound compounds via 
basolateral membrane transporters, followed by metabolism or secretion to the urinary space; 
and 3) synthesis of bioactive substances that are released to peritubular capillaries (Fig. 1).  
 
 
Normal functions of PTCs (indicated by arrows) include: 1) reabsorption and intracellular processing of 
glomerular-filtered substances via apical membrane receptors, transporters, and channels; 2) uptake of 
substances via basolateral membrane transporters followed by metabolism or secretion into the urinary 
space; and 3) synthesis of bioactive substances that are released to peritubular capillaries.  
Fig. 1. Normal functions of proximal tubule cells (PTCs) 
Impairment of these diverse functions is likely to affect systemic hemodynamic and 
metabolic homeostasis and can lead to the development of chronic kidney disease (CKD) 
and cardiovascular disease (CVD) (Saito, Kaseda et al. 2010). In particular, PTC injury occurs 
during the early stages of diabetic nephropathy, a leading cause of CKD.  
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In this review, we focus on actions and interactions of various hormones and hormone-like 
substances on the regulation of apical membrane receptors and transporters that mediate 
three major functions of PTCs: 1) receptor-mediated protein endocytosis, 2) sodium 
reabsorption, and 3) phosphate reabsorption, which are particularly associated with the 
pathophysiology of CKD and the increased risk of CVD (Fig. 2).  
2. Hormonal actions and interactions for regulating protein endocytosis  
in PTCs 
Receptor-mediated endocytosis is a pivotal function of PTCs through which the cells 
reabsorb and metabolize proteins (and other substances) from glomerular filtrates (Saito, 
Sato et al. 2010). This reabsorption process is extremely efficient as urine is virtually protein-
free in humans, and it accounts for the essential conservation of nutrients, carrier-bound 
vitamins, and trace elements filtered by glomeruli. Impairment of the process results in a 
loss of such substances and development of proteinuria.  
2.1 Endocytic receptors involved in protein reabsorption in PTCs 
The two major endocytic receptors expressed at the apical membranes of PTCs are megalin 
and cubilin (Saito, Sato et al. 2010) which act cooperatively in the uptake of glomerular-
filtered proteins and mediate their metabolism in PTCs (Fig. 2). 
 
 
Some hormones, such as dopamine, renalase, vitamin D3 and klotho, are synthesized in PTCs and 
others come from other organs. Renalase acts to metabolize dopamine. 
AMN, amnionless; FGF23, fibroblast growth factor 23; GLP1, glucagon-like peptide 1; NaPi-IIa, sodium-
dependent phosphate cotransporter type IIa; NaPi-IIc, sodium-dependent phosphate cotransporter type 
IIc; NHE3, Na+/H+ exchanger isoform 3; Pit-2, sodium-dependent phosphate symporter 2; PTC, 
proximal tubule cell; PTH, parathormone; SGLT2, sodium-glucose cotransporter 2  
Fig. 2. Hormonal actions and interactions on the functions of receptors and transporters 
involved in receptor-mediated protein endocytosis and reabsorption of sodium and 
phosphate in the apical membrane of PTCs.  
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2.1.1 Megalin  
Megalin is a large (~600 kDa) glycoprotein member of the low-density lipoprotein receptor 
family that is primarily expressed in clathrin-coated pits (Saito, Sato et al. 2010). Megalin-
ligand complexes are internalized by invagination of clathrin-coated pits mediated by 
multiple adaptor proteins and motor molecules, forming endosomal vesicles. Acidification 
of the intravesicular lumen dissociates the ligands from megalin and they are transported to 
lysosomes for degradation or storage or are secreted into the cytosol for further processing 
or transport. Megalin is then recycled to the apical membranes through a recycling 
compartment. Megalin thus plays a critical role in reabsorption and metabolism of 
glomerular-filtered substances including albumin and low molecular weight proteins. 
Vitamin D-binding protein (DBP) is an endocytic ligand of megalin, and megalin knockout 
mice display decreased utilization of vitamin D for its activation in PTCs (Nykjaer et al. 
1999; Leheste et al. 2003) (Fig. 3). 
Decreased megalin expression in PTCs has been observed in the early diabetic stages of 
experimental animals (Tojo et al. 2001; Russo et al. 2007), and it has been suggested that the 
functions of megalin are also impaired in patients during the early stages of diabetic 
nephropathy, since low molecular weight proteinuria is frequently observed in patients at 
these stages (Pontuch et al. 1992; Hong et al. 2003). Therefore, the altered regulation of 
megalin expression and its functions must be primarily responsible for the early 
development of proteinuria/albuminuria in diabetic patients.  
Megalin also interacts with various membrane receptors and transporters such as the 
cubilin/amnionless complex, sodium-hydrogen exchanger isoform 3 (NHE3) and sodium-
dependent phosphate cotransporter type IIa (NaPi-IIa) as discussed in the following 
sections.  
2.1.2 Cubilin  
Cubilin is a 460-kDa peripheral glycoprotein that lacks transmembrane and intracellular 
segments but is anchored to apical PTC membranes. It was originally identified as the 
receptor for intrinsic factor-vitamin B12 complex (Seetharam et al. 1988; Seetharam et al. 
1997). Cubilin requires interaction with megalin to regulate its endocytic functions 
(Yammani, Seetharam, and Seetharam 2001; Kozyraki et al. 2001); however, it is bound 
more firmly by a protein called amnionless forming the complex CUBAM (Fyfe et al. 2004; 
Coudroy et al. 2005). Cubilin gene defects are the cause of hereditary megaloblastic 
anaemia 1 and Imerslund-Gräsbeck syndrome, also known as selective vitamin B12 
malabsorption with proteinuria (Aminoff et al. 1999). Cubilin is also involved in the 
absorption of various protein ligands present in glomerular filtrates, including albumin, 
transferrin and DBP (Christensen, Verroust, and Nielsen 2009). A recent meta-analysis of 
genome-wide association studies identified a missense cubilin gene variant associated 
with levels of albuminuria in both the general population and in diabetic individuals 
(Boger et al. 2011).  
2.1.3 Amnionless  
Amnionless is a 38–50 kDa membrane protein with a single transmembrane domain that 
was initially identified as a component required for normal development of the trunk 
mesoderm derived from the middle streak (Kalantry et al. 2001). In addition, defects of the 
amnionless gene cause hereditary megaloblastic anaemia (Tanner et al. 2003).  
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2.2 Hormones regulating the expression and function of endocytic receptors 
Angiotensin II and insulin are two major hormones involved in regulating the expression 
and function of megalin (Hosojima et al. 2009) (Fig. 2), but no hormones have been 
identified that regulate cubilin and amnionless expression. 
2.2.1 Angiotensin II  
Angiotensin II downregulates the expression and function of megalin via the extracellular-
signal-regulated kinase (ERK)1/2 signaling pathway in cultured PTCs (Hosojima et al. 
2009). Intrarenal levels of angiotensin II are augmented in CKD (Kobori et al. 2007), which is 
involved in the development of hypertension as discussed below. Angiotensin-converting 
enzyme inhibitors and angiotensin II receptor blockers are thus likely to target the increased 
action of angiotensin II in the kidney. These agents may be effective in suppressing the 
reduced expression of megalin in CKD and in preventing proteinuria/albuminuria (Tojo et 
al. 2003).  
Megalin also appears to regulate the intrarenal actions of angiotensin II by internalizing 
angiotensin II (Gonzalez-Villalobos et al. 2005) and angiotensin-(1-7) (Gonzalez-Villalobos et 
al. 2006), as well as mediating the endocytosis of angiotensinogen that is filtered by 
glomeruli (Pohl et al. 2010). 
2.2.2 Insulin  
Insulin is involved in the upregulation of megalin, which in turn may be associated  
with increased endocytosis and metabolism of glomerular-filtered proteins, leading to 
intracellular metabolic overload. Cross-talk between insulin-insulin receptor 
substrate/phosphoinositide 3-kinase and angiotensin II-ERK1/2 signaling pathways  
was previously observed in cultured PTCs (Hosojima et al. 2009), and the balance between 
the actions and interactions of angiotensin II and insulin may also be important in 
regulating the expression of megalin in vivo. Hyperinsulinemia associated with metabolic 
syndrome is thought to stimulate insulin signaling in PTCs, while impaired insulin 
signaling (so-called insulin resistance) is suggested to occur in kidney cells in type 2 
diabetic models; moreover, the intrarenal activation of angiotensin II appears to be 
associated with the development of insulin resistance (Tiwari et al. 2007). Recently, 
megalin was shown to be downregulated by the lipopolysaccharide-tumor necrosis factor-
α-ERK1/2 signaling pathway that may also impair insulin signaling in diabetes 
(Takeyama et al. 2011). In addition, positive control of megalin expression has been 
demonstrated by peroxisome proliferator-activated receptor isoforms peroxisome 
proliferator-activated receptor (PPAR)α and PPARγ and their insulin-sensitizing agonists 
(Cabezas et al. 2011). 
3. Hormonal actions and interactions for regulating sodium reabsorption in 
PTCs 
Sodium reabsorption from glomerular filtrates is an important function of PTCs in the 
maintenance of systemic hemodynamics. Impairment of this function is associated with the 
abnormal regulation of blood pressure, especially in patients with CKD. Moreover, 
increased PTC sodium reabsorption causes glomerular hyperfiltration via the 
tubuloglomerular feedback mechanism, particularly in diabetes (Thomson, Vallon, and 
Blantz 2004). 
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3.1 Major transporters involved in sodium reabsorption and regulated by hormones  
in PTCs 
Various transporters and channels are involved in sodium reabsorption in the apical and 
basolateral membranes of PTCs. Here, we focus on three types of apical transporters (Fig. 2). 
3.1.1 Sodium-hydrogen exchanger isoform 3  
Sodium-hydrogen exchanger isoform 3 (NHE3), the main NHE isoform of PTCs, mediates 
isotonic reabsorption of approximately two-thirds of filtered NaCl and water, the 
reabsorption of bicarbonate, and the secretion of ammonium (Bobulescu and Moe 2009). It 
also contributes to the reabsorption of filtered citrate, amino acids, and oligopeptides by 
providing H+ used by H+-coupled cotransporters. Indeed, enhanced NHE3 activity is 
assumed to be a factor for the increased sodium reabsorption and the development of 
hypertension in diabetes. NHE3 was reported to interact with megalin in PTC 
intermicrovillar clefts (Biemesderfer et al. 1999; Biemesderfer, DeGray, and Aronson 2001) 
and, following endocytosis with megalin, it is postulated to utilize the outward 
transvesicular sodium gradient of endocytic vesicles and early endosomes to drive the 
inward movement of H+ and endosomal acidification. This is important for dissociating 
reabsorbed ligand proteins from megalin both for further processing and megalin recycling 
to the cell surface. Hormonal regulation of NHE3 has been intensively investigated and 
reviewed elsewhere (Bobulescu and Moe 2009). 
3.1.2 Sodium-glucose cotransporter-2 
Glucose is freely filtered by glomeruli before being almost entirely reabsorbed into the 
circulation from PTCs. Reabsorption of the majority of glucose is achieved by sodium-
glucose cotransporter-2 (SGLT2), which is present in the S1 segment of proximal tubules. 
Expression of SGLT2 is enhanced in the kidney of diabetic Zucker rats (Tabatabai et al. 
2009). SGLT2 inhibitors currently in development are expected not only to treat 
hyperglycemia but also to have an effect on hypertension and glomerular hyperfiltration in 
diabetic patients (Bailey et al. 2010; List and Whaley 2011). 
3.1.3 Sodium-dependent phosphate cotransporters  
Sodium-dependent phosphate cotransporters reabsorb inorganic phosphate in a sodium-
dependent manner in PTCs. These will be discussed in detail in section 4.1. 
3.2 Hormones regulating the expression and function of the transporters involved in 
sodium reabsorption in PTCs 
Many hormones are involved in the regulation of sodium reabsorption in PTCs, particularly 
through the function of NHE3 (Fig. 2). 
3.2.1 Angiotensin II  
Angiotensin II is important for increasing sodium uptake by PTCs. Intrarenal levels of 
angiotensin II are augmented in CKD and are also involved in the development of 
hypertension (Kobori et al. 2007; Navar et al. 2011). The action of angiotensin II on NHE3 
has been intensively investigated, indicating biphagic dosage-dependent acute effects and 
chronic stimulatory effects on NHE3 (Bobulescu and Moe 2009). Classically, angiotensin II 
has been thought to act on its specific receptors in PTC plasma membranes by endocrine 
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and local tissue paracrine mechanisms. However, more recently it was also shown to 
function in an autocrine or intracrine manner (Li et al. 2011).  
3.2.2 Insulin  
Insulin is an important hormone that regulates sodium uptake as well as glucose 
metabolism in PTCs. In patients with metabolic syndrome, serum levels of insulin are 
elevated by a mechanism of insulin resistance in the liver and skeletal muscles. Increased 
levels of insulin are likely to augment sodium uptake in PTCs (Baum 1987) as well as other 
nephron segments such as thick ascending limbs (Mandon et al. 1993) and collecting ducts 
(Takahashi, Ito, and Abe 1996), causing extracellular fluid expansion and hypertension. 
Insulin has been shown to acutely and chronically stimulate the function of NHE3 in 
cultured PTCs (Fuster et al. 2007), and its infusion is associated with increased blood 
pressure in rats (Brands et al. 1991) and humans (Gans et al. 1991).  
Diabetic kidneys, however, have been demonstrated to have impaired expression of renal 
insulin receptors (Tiwari et al. 2007). In kidney-specific insulin receptor KO mice, basal 
systolic blood pressure was increased and natriuresis was reduced in response to a volume 
load (Tiwari et al. 2008). The greatest relative reduction of the insulin receptor in these mice 
was found in the thick ascending limb and collecting duct, and renal production of NO was 
likely to be reduced. A previously uncharacterized role of the insulin receptor in these 
nephron segments may thus be associated with sodium and water reabsorption via NO 
production.  
3.2.3 Glucocorticoids  
Glucocorticoids, whether endogenous, as in Cushing syndrome, or exogenous, via 
pharmacologic provision, induce hypertension (Mangos et al. 2003). They directly stimulate 
NHE3 through both acute and chronic mechanisms (Bobulescu and Moe 2009). The acute 
effect of glucocorticoids on cell surface NHE3 is mediated by the activation of HNE3 
exocytosis (Bobulescu et al. 2005) and a glucocorticoid receptor-dependent mechanism that 
activates serum and glucocorticoid-inducible kinase1 (SGK1) in a nongenomic manner 
(Wang et al. 2007). Glucocorticoids have also been found to enhance the function of insulin 
in stimulating NHE3 activity (Klisic et al. 2002).  
3.2.4 Glucagon-like peptide 1 
Glucagon-like peptide 1 (GLP1) receptors are expressed in pancreatic cells and other cells 
such as PTCs (Schlatter et al. 2007). Administration of recombinant GLP1 to Dahl salt-
sensitive rats resulted in an antihypertensive effect, due mainly to its diuretic and natriuretic 
actions (Yu et al. 2003). GLP1 was also found to induce natriuresis in healthy subjects and 
insulin-resistant obese men through its action on PTCs (Gutzwiller et al. 2004). 
Hyperglomerular filtration in obese men was improved following this treatment, which was 
likely to be mediated by tubuloglomerular feedback mechanisms. 
GLP1 receptor agonistic agents have been used in the treatment of hyperglycemia by acting 
on GLP1 receptors in pancreatic ß-cells to stimulate insulin synthesis. The GLP1 receptor 
agonist exendin-4 also decreases sodium reabsorption in PTCs by affecting NHE3 activity 
(Carraro-Lacroix, Malnic, and Girardi 2009) and reduces blood pressure in a salt-sensitive 
hypertension mice model (Hirata et al. 2009). Such agents are also suggested to be clinically 
relevant in reducing blood pressure (Vilsboll et al. 2007; Klonoff et al. 2008). 
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3.2.5 Aldosterone  
Aldosterone stimulates the activity and surface expression of NHE3 in human primary 
PTCs, which is inhibited by the mineralocorticoid receptor blocker spironolactone and by 
the epidermal growth factor receptor (EGFR)-kinase inhibitor (Drumm et al. 2006). 
Aldosterone was found to regulate NHE3 by a nongenomic mechanism (Good, George, and 
Watts 2006). Aldosterone/mineralocorticoid receptor stimulation is also known to affect 
PTCs by inducing cellular senescence (Fan et al. 2011), suggesting that it is a potential 
therapeutic target in CKD. 
3.2.6 Prolactin, dopamine and renalase  
Prolactin is also a natiriuretic hormone that inhibits Na+, K+, ATPase activity in PTCs, 
depending on the renal dopamine system (Ibarra et al. 2005). Dopamine is known to both 
acutely and chronically inhibit the function of NHE3 by reducing its cellular expression 
(Bobulescu and Moe 2009). Renalase, a secreted amine oxidase that is synthesized in the 
kidney, metabolizes circulating catecholamines (Xu et al. 2005). Urinary renalase metabolizes 
urinary catecholamines, and perhaps regulates dopamine concentration in luminal fluid, and 
modulate the function of NHE3 for proximal tubular sodium transport (Desir 2011). 
4. Hormonal actions and interactions for regulating phosphate reabsorption 
in PTCs  
Phosphate uptake is an important function of PTCs which is regulated by the actions and 
interactions of various hormones and hormone-like substances, such as parathormone 
(PTH), fibroblast growth factor 23 (FGF23), klotho, glucocorticoids, vitamin D3, dopamine 
and so on (Figs. 2 and 3). Phosphate regulation is particularly associated with the 
development of cardiovascular disease and high mortality in patients with CKD, 
independently of the glomerular filtration rate (Kestenbaum et al. 2005). Therefore, the 
regulation of phosphate uptake in PTCs is clinically important.  
4.1 Transporters involved in PTC phosphate reabsorption that is hormonally 
regulated  
At least three types of sodium-dependent phosphate transporters have been identified in the 
brush border membrane of PTCs: NaPi-IIa, NaPi-IIc, and sodium-dependent phosphate 
symporter 2 (Pit-2) (Fig. 2). Renal reabsorption of inorganic phosphate is mainly (about 70%) 
mediated by NaPi-IIa in the adult kidney (Ohkido et al. 2003). 
4.1.1 NaPi-IIa  
NaPi-IIa is a major phosphate transporter of PTCs, and changes in renal phosphate handling 
are primarily attributable to altered NaPi-IIa brush border membrane expression (Hernando et 
al. 2005). NaPi-IIa is expressed in the S1–S3 segment of superficial and juxtamedullary 
nephrons (Picard et al. 2010) and mediates the electrogenic transport of inorganic phosphate 
coupled to three sodium ions (Murer, Forster, and Biber 2004). NaPi-IIa is regulated by several 
hormones and other factors, as described in section 4.2. Adequate steady-state expression of 
NaPi-IIa and its inactivation by endocytosis and intracellular translocation require the 
presence of megalin (Bachmann et al. 2004), such that megalin dysfunction is likely to impair 
NaPi-IIa inactivation, inducing the increased reabsorption of phosphate (Fig. 3).  
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In CKD, renal expression of megalin and klotho is decreased, resulting in increased urinary phosphate 
excretion. Decreased megalin expression also causes decreased renal synthesis of 1,25(OH)2 D3. 
Synthesis of FGF23 in the bone is then stimulated, which also suppresses renal 1,25(OH)2 D3 synthesis, 
increasing the synthesis of PTH in the parathyroid. 
Fig. 3. Presumed hormonal network involved in phosphate regulation in CKD 
4.1.2 NaPi-IIc  
NaPi-IIc is a growth-related transporter that is more active in the young and has a reduced 
role in adults (Segawa et al. 2002). NaPi-IIc transports inorganic phosphate in an 
electroneutral fashion and is highly pH dependent, exhibiting more transport at a more 
alkaline pH (Segawa et al. 2002). It is expressed in the S1 segment of PTCs (Picard et al. 
2010) and mutations of the NaPi-IIc gene were found to cause hereditary hypophosphatemic 
rickets with hypercalciuria (HHRH), a Mendelian disorder of renal inorganic phosphate 
reabsorption (Bergwitz et al. 2006; Lorenz-Depiereux et al. 2006). 
4.1.3 Pit-2  
Pit-2, expressed in S1 and weakly in S2 segments of superficial and juxtamedullary 
nephrons (Picard et al. 2010), mediates the electrogenic transport of inorganic phosphate 
(Ravera et al. 2007).  
4.2 Hormones regulating the expression and function of PTC transporters involved in 
phosphate reabsorption  
Several hormones and hormone-like substances are involved in the regulation of phosphate 
cotransporters. In particular, the actions and interactions of PTH, fibroblast growth factor 23 
(FGF23), klotho and vitamin D3 are important in maintaining phosphate homeostasis and 
the development of CKD-mineral bone disease (MBD) (Fig. 2 and 3). 
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4.2.1 PTH  
PTH was first identified as an inactivator of NaPi-IIa through endocytic retrieval and 
degradation (Bacic et al. 2006). It was then found to be also associated with the endocytic 
regulation of NaPi-IIc (Segawa et al. 2007), although its acute effects differentially regulate 
these cotransporters including Pit-2 (Picard et al. 2010). The synthesis of PTH is increased in 
the progression of secondary hyperparathyroidism in CKD.    
4.2.2 FGF23  
FGF23 is a 32-kDa protein that is secreted mainly by bone osteocytes (Liu et al. 2006). 
Administration of FGF23 to mice decreases the renal expression of both NaPi-IIa and NaPi-
IIc and induces hypophosphatemia predominantly via FGF receptor 1 (Gattineni et al. 2009). 
FGF23 also suppresses 1,25(OH)2D3 by inhibiting 1α-hydroxylase (CYP27B1), which 
converts 25-hydroxyvitamin D3 [25(OH)D3] to 1,25(OH)2D3, and by stimulating 24-
hydroxylase (CYP24), which converts 1,25(OH)2D3 to inactive metabolites in PTCs (Shimada 
et al. 2004). Increased FGF23 appears to play a causative role in the abnormal renal 
phosphate handling and vitamin D3 metabolism of rats with CKD, leading to the 
development of secondary hyperparathyroidism and increased production of PTH 
(Hasegawa et al. 2010). The ternary complex of klotho-FGF23-FGF receptor in distal 
convoluted tubules (DCTs) has been thought to be a prerequisite for the exertion of FGF23 
effects (Kurosu et al. 2006), and, indeed, initial FGF23-mediated signaling occurs in DCTs 
(Farrow et al. 2009). However, it remains undetermined how FGF23-mediated signaling in 
DCTs leads to the regulation of NaPi-IIa and NaPi-IIc in PTCs. It may be possible that 
FGF23 has a direct action on PTCs (Huang and Moe 2011).  
4.2.3 Klotho  
Klotho was first identified as an aging suppressor gene product (Kuro-o et al. 1997). It is a 
single-pass transmembrane protein expressed predominantly in the kidney, intensely in 
DCTs and to a lesser extent in PTCs and parathyroid gland (Kuro-o 2011). Klotho–/– and 
Fgf23–/– mice show very similar phenotypes such as premature aging and abnormal mineral 
metabolism (Kuro-o 2011). As mentioned above, klotho acts with FGF receptor as a 
coreceptor in the binding of FGF23 in DCTs for phosphate and vitamin D3 regulation 
(Kurosu et al. 2006). The Klotho-FGF23-FGF receptor complex in DCTs may produce 
putative paracrine factors on PTCs where phosphate transporters and enzymes for vitamin 
D3 regulation are located (Huang and Moe 2011). The extracellular domain of Klotho is also 
known to be cleaved from plasma membranes, secreted to the circulatoin and present in 
urine (Hu et al. 2011); this soluble klotho form may directly act on PTCs. Klotho was also 
found to act as a PTC-synthesized autocrine factor in the FGF23-independent inhibition of 
NaPi-IIa function by ß-glucuronidase-like enzymatic activity (Hu et al. 2011). Decreased 
Klotho expression in the kidney may be one of initial factors triggering dysregulation of 
various hormones involved in phosphate homeostasis and the development of secondary 
hyperparathyroidism in CKD (Kuro-o 2011). 
4.2.4 Vitamin D3  
As mentioned above, megalin and cubilin take up the 25(OH)D3/DBP complex from 
glomerular filtrates (Nykjaer et al. 1999; Nykjaer et al. 2001; Leheste et al. 2003). In PTCs, 
25(OH)D3 is dissociated from DBP and converted by 1α-hydroxylase to the biologically 
active form 1,25(OH)2D3, which is released to peritubular capillaries. Therefore, dysfunction 
of these endocytic receptors is an important cause of deficiency of both 25(OH)D3 and 
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1,25(OH)2D3 in CKD. The activation of vitamin D3 is also upregulated by PTH and 
downregulated by FGF23 (Shimada et al. 2004). Vitamin D3 deficiency develops very early 
in the course of CKD, especially in diabetic nephropathy, and is associated with the 
development of CVD or mortality in patients at the predialysis stage (Mehrotra et al. 2009).  
4.2.5 Other hormones  
Dopamine mediates renal phosphate excretion, which is affected by the function of renalase 
(Weinman et al. 2011). Chronic infusion of angiotensin II into rats was demonstrated to 
increase the expression of NaPi-IIa in PTC brush border membranes by posttranscriptional 
mechanisms (Xu et al. 2004). This increase of NaPi-IIa may be associated with an angiotensin 
II-mediated decrease in the expression of megalin that plays a role in endocytosis and the 
degradation of NaPi-IIa (Bachmann et al. 2004). Insulin may also be involved in regulating 
sodium-dependent phosphate transporters (Kunkler et al. 1991; Li et al. 1996). 
Glucocorticoids inhibit phosphate uptake in primary cultured rabbit PTCs via both 
nongenomic and genomic mechanisms (Park, Taub, and Han 2001). In addition, estrogen 
causes the PTH-independent downregulation of NaPi-IIa in PTCs (Faroqui et al. 2008).  
5. Conclusion 
There are a variety of hormonal actions and interactions involved in the regulation of 
important PTC functions such as receptor-mediated endocytosis and the reabsorption of 
sodium and phosphate. The impaired counterbalance of these hormones is likely to be 
associated with the development and/or progression of CKD. Elucidation of the 
mechanisms of such hormonal actions and interactions would therefore be of great benefit 
in the future development of novel therapeutic strategies for CKD. 
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